KIRKLAND, QC, Sept. 15, 2020 /CNW/ - Merck Canada Inc., an affiliate of Merck & Co., Inc., known as MSD outside the United States and Canada, announced today that Health Canada has approved BRENZYS ®, ...
KENILWORTH, N.J. & SEOUL, South Korea--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. today announced the approval of BRENZYS™ ...
A 20-year-old female presented with a history of psoriasis and psoriatic arthritis since childhood. She started treatment with etanercept (Enbrel ®) 1 month previously. One day after a subcutaneous ...
On September 15, 2020, Merck Canada Inc., an affiliate of Merck & Co., Inc., announced that Health Canada approved BRENZYS® (etanercept) for the following additional indications: Adult patients with ...
INCHEON, Republic of Korea, September X, 2015 – Samsung Bioepis – the South Korean-based biopharmaceutical company, announced today that MFDS, the South Korean regulatory authority, has approved ...
If you have certain types of arthritis or plaque psoriasis, your doctor may prescribe Enbrel. It’s used to treat the following conditions: Enbrel contains the active drug etanercept, which is a ...
Doctors prescribe Enbrel for arthritis, psoriasis, and other conditions. The medication can cause side effects that are mild and some serious ones. Serious side effects of Enbrel include neurologic ...
May 23, 2005 — The European Commission has approved a 50-mg/mL formulation of etanercept injection for the treatment of rheumatoid arthritis, and the U.K.'s Medicine and Healthcare Products Regulatory ...
INCHEON, KOREA--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced its expansion into the Brazilian biopharmaceutical market. The first product available in the country is BRENZYS™ (etanercept ...
Last week Pfizer filed a lawsuit in a federal court of Australia against respondents Samsung Bioepis, Merck, Sharp & Dohme, Organon, and Arrow, to halt sales of their biosimilar BRENZYS (etanercept).
The government of Australia’s pricing policy links the price of new medications with similar safety and efficacy, resulting in significant savings over the first 3 years after the etanercept ...
The FINANCIAL — Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd. on September 8 announced the approval of BRENZYS (etanercept), a biosimilar of the immunology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results